Polyphenolic extract of Ichnocarpus frutescens modifies hyperlipidemia status in diabetic rats

Journal of Cell and Molecular Biology

Volumn 6, Issue 2, 2007, Pages 175-187

  Kumarappan, Chidambaram T ^a   Rao, T Nageswara ^a   Mandal, Subhash C ^a  

^a JADAVPUR UNIVERSITY   (India)

Author keywords

Alloxan; Diabetes; Hyperlipidemia; Ichnocarpus frutescenes; Polyphenolic extract

Indexed keywords

ANTIDIABETIC AGENT; CHOLESTEROL; HEPARIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; ICHNOCARPUS FRUTESCENS EXTRACT; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLANT EXTRACT; POLYPHENOL DERIVATIVE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; FEMALE; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HYPERLIPIDEMIA; HYPOLIPEMIA; ICHNOCARPUS FRUTESCENS; MALE; MEDICINAL PLANT; MORNING DOSAGE; NONHUMAN; OBESITY; PLANT LEAF; PROTEIN EXPRESSION; RAT; THROMBOCYTE AGGREGATION INHIBITION;

RATTUS;

EID: 43249123785     PISSN: 13033546     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Aviram M and Fuhrman B. Wine Flavonoids Protect against LDL Oxidation and Atherosclerosis. Ann N Y Acad Sci. 957:146-161, 2002.
2. Bailey JW and Day C. Traditional treatments for diabetes. Diabete Care. 12:553-564, 1989.
3. Bainton D, Miller NE, Botton CH, JWG, Suretman, PM, Baker IA, Lewis B and Elmood PC. Plasma triglyceride and high density lipo-protein cholesterol a predictors of ischemic heart disease in Britain man. Br. Heart. J. 68: 60-66, 1992.
4. Bhandary MJ, Chandrashekar K.R and Kaveriappa KM. Medical Ethno-botany of the Siddis of Uttara Kannada District, Karnataka, India. J. Ethnopharmacol. 47: 149-158, 1995.
5. Chang CC, Yang MH, Wen HM and Chern JC. Estimation of total flavonoid content in propolis by two complementary colorimetric methods. J. Food. Drug. Anal. 10: 178-182, 2002.
6. Chiquette, E. and Chilton R. Cardiovascular disease: much more aggressive in patients with type 2 diabetes. Curr. Atherosclerosis Reports. 4: 134-142, 2002.
7. Daniel M and Sabnis SD. Chemotaxonomical studies on Apocynaceae. Indian J. Exp. Biol. 16: 512-513, 1978.
8. De sereday M, Gonzalez C, Giorgini D, De Loredo Braguinsky J, Cobenas C, Tebone C and Libman C. Diabetes Metab. 30: 335-339, 2004.
9. Du Thie G and Crozier A. Plant derived polyphenolic antioxidants. Curr. Opin. Nutr. Metab. 3: 447-451, 2000.
10. Elisaf M, Bairakari H, Tzaiallas C, Germanos N and Siamopoulos K. Dial. Transplant. 24: 642-650, 1995.
11. Erah PO, Osuide GE and Omogbai EKI. Hypoglycemic effect of the extract of Solenostemon monostachys leaves. J. West. Afr. Pharm. 10: 21-27, 1996.
12. Friedwald's WT, Levy IR and Friedrickson SD. Estimation of concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18: 499-502, 1972.
13. Fuhrman B and Aviram M. Flavonoids protect LDL from oxidation arid attenuate atherosclerosis. Curr. Opin. Lipidol.12: 41-48, 2001.
14. Galigher AE and Kozloff EN. Essential of practical microtechnique. Pp. 77. 2nd Edition. Lea and Jehiger. Philadelphia, 1971.
15. Goldstein JL, Schrott HG, Hazzard WR, Bierman EL and Motulsky AG. Hyperlipidemia in coronary heart disease 11. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined gyperlipidemia. J. Clin. Invest. 52: 1544-1568, 1973.
16. Henry RJUM. Clinical Chemistry. Pp. 1440-1443. Harper and Row Publishers, New York, 1974.
17. Hishikawa K, Nakaki T and Fujita T. Oral flavonoid supplementation attenuates atherosclerosis development in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 2005: 442-446, 2005.
18. Hong J, Smith TJ, Ho CT, August DA and Yang CS, Effects of purified green and black tea polyphenols on cyclooxygenase and lipoxygenase-dependent metabolism of arachidonic acid in human colon mucosa and colon tumor tissues. Biochem. Pharmacol 62: 1175-1183, 2001.
19. Huang X, Vagg A, Hanson M, Weng J and Goop L. Impaired insulin stimulated expression of the glycogen synthage gene in skeletal muscle of type 2 diabetic patients in acquired rather than inherited. J. Clin. Endocrinol. Metab. 85: 1584-1590, 2000.
20. Hwang HJ Kim SW, Lim JM, Joo JH, Kim HO, Kim HM and Yun JW. Hypoglycemic effect of crude exopolysaccharides produced by a medicinal mushroom Phellinus baumii in streptozotocin-induced diabetic rats. Life. Sci. 76: 3069-3080, 2005.
21. Kaplan M, Hayek T, Raz A, Coleman R, Domfeld L, Vaya J and Aviram M. Pomegranate juice supplementation to atherosclerotic mice reduces macrophage lipid peroxidation, cellular cholesterol accumulation and development of atherosclerosis. J. Nutr. 131: 2082-2089, 2001.
22. Kaur J, Singh P and Sowers JR. Diabetes and cardiovascular diseases. Am. J. Ther. 9: 510-515, 2002.
23. Kedar P and Chakrabarti CH. Effect of bitter gourd (Momordica charantia) seed and glibenclamide in Streptozotocin induced diabetes mellitus. Indian J. Exp. Biol. 20: 232-235, 1982.
24. Khan CR and Schchter Y. Oral hypoglycemic agents and the pharmacology of endocrine pancreas. In: Goodman and Gilman's The Pharmacological Basis of Therapeutics. Pp. 1463-1495. New York, Pergamon Press, 1991.
25. Kom ED. Lipoprotein Lipase (Clearing factor) In: Methods in Enzymology, Vol V, Pp.542-545. Academic Press, New York, 1962.
26. Krishnakumar K, August KT and Vijayammal PL. Hypolipidemic effect of Salacia oblonga Wall. Root bark in Streptozotocin diabetic rats. Med Scie. Res. 28, 65-67, 2000.
27. Lakshmi DKM, Venkata Rao E and Venkata Rao D. Triterpnoid constituents of Ichnocarpus frutescens. Indian Drugs. 22: 552-553, 1985.
28. Lowery OH, Roesborough MJ, Farr AL and Randall RJ. Protein measurement with Folinphenol reagent. J. Biol. Chem. 193: 265-275, 1951.
29. Luceri C, Giannini L, Lodovici M, Antonucci E, Abbate R, Masini E, and Dolara, P. pCoumaric acid, a common dietary phenol, inhibits platelet activity in vitro and in vivo. Brit. J. Nutr. 97: 458-463, 2007.
30. Marles RJ and Farnsworth NR. Antidiabetic plants and their active constituents. Phytomedicine. 2:137-189, 1995.
31. Mary NK, Babu BH and Padikkala J. Antiatherogenic effect of Caps HT2, a herbal Ayurvedic medicine formulation. Phytomedicine 10: 474-482, 2003.
32. Miyake Y, Suzuki E, Ohya S, Fukumoto S. Hirmitsu M, Sakaida K, Osawa T and Furuichi Y. Lipid-Lowering Effect of Eriocitrin, the Main Flavonoid in Lemon Fruit, in Rats on a High-Fat and High-Cholesterol Diet. J. Food. Scie. 71: S633-S637, 2006.
33. Muruganandan, S, Srinivasan, K, Gupta, S, Gupta, PK and Lal J. Effect of mangiferin on hyperglycemia and atherogenicity in streptozotocin diabetic rats. J. Ethnopharmacol. 97: 497-501, 2005.
34. Mustard JF, Packham MA and Kinlough-Rathbone RL. Platelets, blood flow and the vessel wall. Circulation. 81: 124-127, 1990.
35. OECD (Organization for Economic Co-operation and Development). OECD Guidelines for the Testing of Chemicals/Section 4: Health Effects Test No. 423: Acute Oral Toxicity - Acute Toxic Class Method. OECD, Paris, 2002.
36. Parinitha M, Harish GU, Vivek NC, Mahesh T and Shivanna MB. Ethno-botanical wealth of Bhadra wild life sanctuary in Karnataka. Indian J. Trad. Knowledge. 31:37-50, 2004.
37. Patel K and Srinivasan K. Plants food in the management of diabetes mellitus: Vegetables as potential hypoglycemic agents. Nahrung, 41: 68-74, 1997.
38. Pignatelli P, Lenti L, Pulcinelli FM, Catasca R, Saccani G, Germano G, Marcoccia A,, Silvestri MA, Ghiselli A and Violi F. Red and white wine differently affect collagen-induced platelet aggregation. Pathophysiol Haemost Thromb 32: 356-358, 2002.
39. Rao AV and Ramakrishnan S. Indirect assessment of hydroxymethyl glutaryl CoA reductase (NADPH) activity in liver tissue. Clin. Chem. 21: 1523-1525, 1975.
40. Reaven GM. Role if insulin resistance in human disease. Diabetes. 37: 1595-1607, 1988.
41. Rhoads GG, Gulbrandse CL and Kagan A. Serum lipoproteins and coronary artery disease in a population study of Hawaiian Japanese Men. N. Eng. J. Med. 294: 293-298, 1976.
42. Ruf JC. Wine and polyphenols related to platelet aggregation and atherothrombosis. Drugs Exp. Clin., Res. 25:125-131, 1999.
43. Saravanan R, and Pari L. Antihyperlipidemic and antiperoxidative effect and Diasulin, a polyherbal formulation in alloxan induced hyperglycemic rats. BMC Compl. Alt. Med. 5: 14, 2005.
44. Sharma SB, Nasir A, Prabhu KM, Murthy PS and Dev G. J. Ethnopharmacol. 85: 201-206, 2003.
45. Sheetz MJ. Molecular understanding of hyperglycemias adverse effects for diabetic complications. J. Am. Med. Assoc. 288: 2579-2588, 2002.
46. Simons LA. Additive effect of plant sterol-ester margarine and cerivastatin in towering low-density lipoprotein cholesterol in primary hypercholesterolemia. Am. J. Cardiol. 90: 737-740, 2002.
47. Singh RP and Singh RP. Flavonoids of the flowers of Ichnocarpus frutescens. J Indian Chem. Soc. LXIV: 715-756, 1987.
48. Singleton VL, Orthofer RM and Ramuela-Raventos RM. Analysis of total phenols and antioxidants and other substrates by means of Folin-Ciocalteu reagent. Methods. Enzymol. 29: 152-78, 1999.
49. Subramaniam A and Satyanarayana MN. Influence of certain dietary plant constituents on platelet aggregation. J Food Safety. 9: 201-214, 1989.
50. Szkudelski T. The Mechanism of alloxan and Streptozotocin action in β-cells of the rat pancreas. Physiol. Res. 50: 536-546, 2001.
51. Taskimen MR. Lipiprotin lipase in diabetes. Diabetes Metab. Rev. 3: 551-570, 1987.
52. Timmis AD. Diabetes: Relationship to ischaemic heart diseases. Br. Med. Bull. 59: 159-172, 2001.
53. Vats RK, Kumar V, Kothari A, Mital A and Ramachandran U. Emerging targets for diabetes. Curr. Scie. 88: 241-249, 2005.
54. Vessal M, Hemmati M and Vasei M. Antidiabetic effects of quercetin in Streptozotocin induced diabetic rats. Comp. Biochem. Physiol. Part C. 135: 357-364, 2003.
55. Vinson JA and Zhang J. Black and green teas equally inhibit diabetic cataracts in a streptozotocin-induced rat model of diabetes. J. Agric. Food Chem. 53: 3710-3713, 2005.
56. Wagner ME and Bladt S. Plant drug analysis. Pp. 55-76. Springer-Verlag, Berlin: Germany, 1996.
57. West IC. Radicals and Oxidative stress in diabetes. Diab. Med. 17: 171-180, 2000
58. Whitton PD and Hems DA. Glycogen synthesis in perfused liver of Streptozotocin diabetic rats. Biochem. J. 150: 153-159, 1975.
59. Wilson GL, Patton NJ, McCord JM, Mullins DW, and Mossman BT. Mechanism of streptozotocin and alloxan induced damage in rat beta cells. Diabetologia. 27: 587-591, 1984.